litlas
ログインアカウント作成

Balázs Halmos

2002–2026 年に発表

別表記
Balazs Halmos
111
論文数
22,427
被引用数
58
h 指数
103
i10 指数

被引用数

Balázs Halmos の年別被引用数1971 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 1 件1994 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 7 件2004 年: 被引用 14 件2005 年: 被引用 61 件2006 年: 被引用 132 件2007 年: 被引用 168 件2008 年: 被引用 152 件2009 年: 被引用 142 件2010 年: 被引用 153 件2011 年: 被引用 167 件2012 年: 被引用 156 件2013 年: 被引用 233 件2014 年: 被引用 196 件2015 年: 被引用 214 件2016 年: 被引用 207 件2017 年: 被引用 195 件2018 年: 被引用 206 件2019 年: 被引用 719 件2020 年: 被引用 1,087 件2021 年: 被引用 1,208 件2022 年: 被引用 865 件2023 年: 被引用 581 件2024 年: 被引用 822 件2025 年: 被引用 393 件2026 年: 被引用 10 件1972〜1986 年は被引用が無いため表示していません1989〜1993 年は被引用が無いため表示していません1995〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,936 件、この内訳の 24.9%中国: 引用元論文 1,671 件、この内訳の 14.1%日本: 引用元論文 719 件、この内訳の 6.1%イタリア: 引用元論文 676 件、この内訳の 5.7%イギリス: 引用元論文 533 件、この内訳の 4.5%フランス: 引用元論文 486 件、この内訳の 4.1%ドイツ: 引用元論文 465 件、この内訳の 3.9%スペイン: 引用元論文 454 件、この内訳の 3.8%カナダ: 引用元論文 320 件、この内訳の 2.7%韓国: 引用元論文 317 件、この内訳の 2.7%スイス: 引用元論文 254 件、この内訳の 2.2%オーストラリア: 引用元論文 247 件、この内訳の 2.1%
0%24.9%その他 23.2%

機関

分野

  • Medicine74.8%
  • Biochemistry, Genetics and Molecular Biology18%
  • Immunology and Microbiology4%
  • Chemistry0.6%
  • Computer Science0.6%
  • Engineering0.4%
  • その他1.6%

トピック

  • Lung Cancer Treatments and Mutations13.6%
  • Cancer Immunotherapy and Biomarkers9.6%
  • Lung Cancer Research Studies6.1%
  • Lung Cancer Diagnosis and Treatment4%
  • Cancer Genomics and Diagnostics3.2%
  • HER2/EGFR in Cancer Research2.3%
  • その他61.2%

共著者

全論文

検索で開く
  1. Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

    著者: Luis Paz‐Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Bárbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp, Jerónimo Rafael Rodríguez‐Cid, Jonathan Wilson, Shunichi Sugawara, Terufumi Kato, Ki Hyeong Lee, Ying Cheng, Silvia Novello, Balázs Halmos, Xiaodong Li, Gregory M. Lubiniecki, Bilal Piperdi, Dariusz M. Kowalski - New England Journal of Medicine 2018 被引用: 3,642

  2. Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

    著者: Silvia Novello, Dariusz M. Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente, Julien Mazières, Jerónimo Rafael Rodríguez‐Cid, Ali Tafreshi, Ying Cheng, Ki Hyeong Lee, Alexander Golf, Shunichi Sugawara, Andrew Robinson, Balázs Halmos, Erin Jensen, Paul Schwarzenberger, M. Catherine Pietanza, Luis Paz‐Ares - Journal of Clinical Oncology 2023 被引用: 512

  3. EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

    著者: Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos - New England Journal of Medicine 2005 被引用: 3,939

  4. A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

    著者: Luis Paz‐Ares, David Vicente, Ali Tafreshi, Andrew Robinson, Héctor Soto Parrà, Julien Mazières, Bárbara Hermes, İrfan Çiçin, Balazs Medgyasszay, Jerónimo Rafael Rodríguez‐Cid, Isamu Okamoto, Sung-Sook Lee, Rodryg Ramlau, Vladimir Vladimirov, Ying Cheng, Xuan Deng, Ying Zhang, Tuba Öcek Baş, Bilal Piperdi, Balázs Halmos - Journal of Thoracic Oncology 2020 被引用: 645

  5. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

    著者: Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D. Levine, Jin Kyung Rho, Yun Jung Choi, Chang‐Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung‐Shin Lee, Vincent A. Miller, Maria E. Arcila, Marc Ladanyi, Philicia Moonsamy, Charles L. Sawyers, Titus J. Boggon, C. Patrick, Carlota Costa, Miquel Tarón, Rafael Rosell, Balázs Halmos, Trever G. Bivona - Nature Genetics 2012 被引用: 1,220

  6. Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations

    著者: Alexa B. Schrock, Garrett M. Frampton, James Suh, Zachary R. Chalmers, Mark R. Rosenzweig, Rachel Erlich, Balázs Halmos, Jonathan W. Goldman, Patrick M. Forde, Kurt Leuenberger, Nir Peled, Gregory P. Kalemkerian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Sai‐Hong Ignatius Ou - Journal of Thoracic Oncology 2016 被引用: 381

  7. Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

    著者: Ryohei Katayama, Alice T. Shaw, Tahsin Khan, Mari Mino–Kenudson, Benjamin Solomon, Balázs Halmos, Nicholas A. Jessop, John C. Wain, Alan T. Yeo, Cyril H. Benes, Lisa Drew, Jamal Saeh, Katherine Crosby, Lecia V. Sequist, A. John Iafrate, Jeffrey A. Engelman - Science Translational Medicine 2012 被引用: 1,326

  8. Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3

    著者: Ishmael Jaiyesimi, Natasha B. Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish M. Gadgeel, Gregory A. Masters, Erin L. Schenk, Bryan J. Schneider, Lecia V. Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman‐Daily, Naoki Furuya, Balázs Halmos, Ibrahim Azar, Sara Kuruvilla, Michael P. Mullane, Jarushka Naidoo, Joshua E. Reuss, David R. Spigel, Dwight H. Owen, Jyoti D. Patel - Journal of Clinical Oncology 2024 被引用: 82

  9. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3

    著者: Ishmael Jaiyesimi, Natasha B. Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish M. Gadgeel, Gregory A. Masters, Erin L. Schenk, Bryan J. Schneider, Lecia V. Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman‐Daily, Naoki Furuya, Balázs Halmos, Ibrahim Azar, Sara Kuruvilla, Michael P. Mullane, Jarushka Naidoo, Joshua E. Reuss, David R. Spigel, Dwight H. Owen, Jyoti D. Patel - Journal of Clinical Oncology 2024 被引用: 55

  10. Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

    著者: Shirish M. Gadgeel, Nathan A. Pennell, Mary J. Fidler, Balázs Halmos, Philip Bonomi, James Stevenson, Bryan J. Schneider, Ammar Sukari, Jaclyn Ventimiglia, Wei Chen, Cathy Galasso, Antoinette J. Wozniak, Julie L. Boerner, Gregory P. Kalemkerian - Journal of Thoracic Oncology 2018 被引用: 224

  11. Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

    著者: Luis Paz‐Ares, Yasushi Goto, Wan‐Teck Lim, Balázs Halmos, Byoung Chul Cho, Manuel Cobo, J.L. González-Larriba, Caicun Zhou, Ingel Demedts, Akin Atmaca, Sofia Baka, Bijoyesh Mookerjee, Socorro Portella, Zewen Zhu, Jincheng Wu, David Demanse, Bharani Dharan, Martin Reck - Lung Cancer 2024 被引用: 48

  12. Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

    著者: Marina Chiara Garassino, Shirish M. Gadgeel, Silvia Novello, Balázs Halmos, Enriqueta Felip, Giovanna Speranza, Rina Hui, Edward B. Garon, Hidehito Horinouchi, Shunichi Sugawara, Delvys Rodríguez‐Abreu, Martin Reck, Răzvan Cristescu, Deepti Aurora-Garg, Andrey Loboda, Jared Lunceford, Julie Kobie, Mark Ayers, Bilal Piperdi, M. Catherine Pietanza, Luis Paz‐Ares - JTO Clinical and Research Reports 2022 被引用: 42

  13. Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up

    著者: Shirish M. Gadgeel, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, Luis Paz‐Ares - Journal of Thoracic Oncology 2024 被引用: 36

  14. Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

    著者: George N. Naumov, Monique B. Nilsson, Tina Cascone, Alexandra Briggs, Oddbjørn Straume, Lars A. Akslen, Eugene Lifshits, Lauren A. Byers, Li Xu, Hua-Kang Wu, Pasi A. Jänne, Susumu Kobayashi, Balázs Halmos, Daniel G. Tenen, Xiaoou Tang, Jeffrey A. Engelman, Beow Y. Yeap, Judah Folkman, Bruce E. Johnson, John V. Heymach - Clinical Cancer Research 2009 被引用: 348

  15. Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

    著者: Hossein Borghaei, Corey J. Langer, Luis Paz‐Ares, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino, Baerin Houghton, Takayasu Kurata, Ying Cheng, Jianxin Lin, M. Catherine Pietanza, Bilal Piperdi, Shirish M. Gadgeel - Cancer 2020 被引用: 111

  16. Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis

    著者: Juan Jiang, Yuling Wang, Yang Gao, Haruhiko Sugimura, Fabrizio Minervini, Junji Uchino, Balázs Halmos, Sai Yendamuri, Jeffrey B. Velotta, Min Li - Translational Lung Cancer Research 2022 被引用: 72

  17. Selective Personalized RadioImmunotherapy for Locally Advanced Non–Small-Cell Lung Cancer Trial (SPRINT)

    著者: Nitin Ohri, Shruti Jolly, Benjamin T. Cooper, Rafi Kabarriti, William Bodner, Jonathan Klein, Chandan Guha, V. Shankar, Elaine Shum, Joshua K. Sabari, Haiying Cheng, Rasim Gucalp, Enrico Castellucci, Angel Qin, Shirish M. Gadgeel, Balázs Halmos - Journal of Clinical Oncology 2023 被引用: 60

  18. Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

    著者: Melissa L. Johnson, James Strauss, Manish R. Patel, Edward B. Garon, Keith D. Eaton, Tavette Neskorik, Josée Morin, Richard C. Chao, Balázs Halmos - Clinical Lung Cancer 2023 被引用: 24

  19. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

    著者: Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri, Daniel Flora, Elizabeth A. Griffiths, Anthony P. Gulati, Clara Hwang, Vadim S. Koshkin, Esperanza B. Papadopoulos, Elizabeth Robilotti, Christopher Su, Elizabeth Wulff‐Burchfield, Zhuoer Xie, Peter Paul Yu, Sanjay Mishra, Jonathon W. Senefeld, Dimpy P. Shah, Jeremy L. Warner, Balázs Halmos, Amit Verma, Benjamin A. Gartrell, Sanjay Goel, Nitin Ohri, R. Alejandro Sica, Astha Thakkar, Keith Stockerl‐Goldstein, Omar H. Butt, Jian Campian, Mark A. Fiala, Ryan Monahan, Alice Y. Zhou, Pamela Bohachek, Daniel Mundt, Mitrianna Streckfuss, Eyob Tadesse, Philip E. Lammers, Sanjay G. Revankar, Orestis A. Panagiotou, Pamela Egan, Dimitrios Farmakiotis, Hina Khan, Adam J. Olszewski, Arturo Loaiza‐Bonilla, Salvatore A. Del Prete, Anne H. Angevine, Michael Bär, KM Steve Lo, Jamie Stratton, Paul L. Weinstein, Paolo F. Caimi, Jill S. Barnholtz‐Sloan, Jorge A. García, John Nakayama, Shilpa Gupta, Nathan A. Pennell, Manmeet S. Ahluwalia, Scott J. Dawsey, Amanda Nizam, Christopher A. Lemmon, Claire Hoppenot, Ang Li, Ziad Bakouny, Gabrielle Bouchard, Fiona Busser, Jean M Conners, Catherine Curran, George D. Demetri, Antonio Giordano, Kaitlin M. Kelleher, Anju Nohria, Andrew Schmidt, Grace Shaw, Eliezer M. Van Allen, Pier Vitale Nuzzo, Wenxin Xu, Rebecca L. Zon, Tian Zhang, Susan Halabi, Gary H. Lyman, Jerome Graber, Petros Grivas, Ali Raza Khaki, Elizabeth T. Loggers, Ryan C. Lynch, Elizabeth S. Nakasone, Michael T. Schweizer, Lisa ML Tachiki, Shaveta Vinayak, Michael J. Wagner, Albert C. Yeh, Na Tosha Gatson, Sharad Goyal, Minh‐Phuong Huynh‐Le, Lori J. Rosenstein, Jessica Clément, Ahmad Daher, Mark E. Dailey ほか 181 名 - JAMA Oncology 2021 被引用: 185

  20. Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia

    著者: Mohamed Bentires‐Alj, J. Guillermo Paez, Frank David, Heike Keilhack, Balázs Halmos, Katsuhiko Naoki, John M. Maris, Andrea L. Richardson, Alberto Bardelli, David J. Sugarbaker, William G. Richards, Jinyan Du, Luc Girard, John D. Minna, Mignon L. Loh, David E. Fisher, Victor E. Velculescu, Bert Vogelstein, Matthew Meyerson, William R. Sellers, Benjamin G. Neel - Cancer Research 2004 被引用: 513

  21. BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

    著者: Daniel B. Costa, Balázs Halmos, Amit Kumar, Susan Schumer, Mark S. Huberman, Titus J. Boggon, Daniel G. Tenen, Susumu Kobayashi - PLoS Medicine 2007 被引用: 491

  22. Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations

    著者: Xuewen Liu, Yuxia Jia, Mark Stoopler, Yufeng Shen, Haiying Cheng, Jinli Chen, Mahesh Mansukhani, Sanjay Koul, Balázs Halmos, Alain Borczuk - Journal of Clinical Oncology 2015 被引用: 341

  23. Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human Cancer

    著者: Amit Kumar, Edward T. Petri, Balázs Halmos, Titus J. Boggon - Journal of Clinical Oncology 2008 被引用: 308

  24. Impact of chronic obstructive pulmonary disease on immune checkpoint inhibitor efficacy in advanced lung cancer and the potential prognostic factors

    著者: Jiebai Zhou, Yencheng Chao, Danwei Yao, Ning Ding, Jiamin Li, Lei Gao, Yong Zhang, Xiaobo Xu, Jian Zhou, Balázs Halmos, Nikolaos Tsoukalas, Yuki Kataoka, Ramon Andrade de Mello, Yuanlin Song, Jie Hu - Translational Lung Cancer Research 2021 被引用: 56